Coeptis Therapeutics Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Coeptis Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2021.
  • Coeptis Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was -$80K, a 108% decline year-over-year.
  • Coeptis Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2022 was -$3.36M, a 608% decline year-over-year.
  • Coeptis Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $784K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $784K +$3.08M Jan 1, 2021 Dec 31, 2021 10-K 2022-03-11
2020 -$2.29M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.